Fig. 2From: Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapyThe overall treatment period (≤48 days) was a significant predictor of the overall survival rate (p = 0.024)Back to article page
